{
    "id": "0234",
    "question": "A 55-year-old man comes to the physician because of a 3-month history of a progressively growing mass in his axilla. During this period, he has had recurrent episodes of low-grade fever lasting for 7 to 10 days, and an 8-kg (18-lb) weight loss. His only medication is a multivitamin. Physical examination shows nontender, right axillary, cervical, and inguinal lymphadenopathy. His serum calcium concentration is 15.1 mg/dL and parathyroid hormone (PTH) concentration is 9 pg/mL. A lymph node biopsy shows granuloma formation and large CD15-positive, CD30-positive cells with bilobed nuclei. Which of the following is the most likely explanation for this patient's laboratory findings?",
    "options": {
        "A": "Excessive intake of dietary ergocalciferol",
        "B": "Induction of focal osteolysis by tumor cells",
        "C": "Secretion of \u03b3-interferon by activated T-lymphocytes",
        "D": "Production of PTH-related peptide by malignant cells"
    },
    "answer": "C",
    "predict": "To approach this question, let's break down the key findings and analyze them step by step: 1. **Clinical Presentation**: The patient presents with a progressively growing mass in the axilla, recurrent low-grade fever, and significant weight loss. These symptoms suggest a systemic illness, possibly a malignancy. 2. **Physical Examination Findings**: The presence of nontender lymphadenopathy in multiple regions (axilla, cervical, and inguinal) is indicative of a lymphoproliferative disorder. 3. **Laboratory Findings**: - Elevated serum calcium concentration (15.1 mg/dL) suggests hypercalcemia. - Low parathyroid hormone (PTH) concentration (9 pg/mL) is unusual, as PTH is typically elevated in primary hyperparathyroidism or other conditions that lead to hypercalcemia. - The lymph node biopsy shows granuloma formation and large, CD15-positive, CD30-positive cells with bilobed nuclei. This histological description is highly suggestive of Hodgkin lymphoma, specifically a subtype known as mixed cellularity Hodgkin lymphoma. Given these findings, let's evaluate the answer choices: A. **Excessive intake of dietary ergocalciferol**: This would lead to hypercalcemia but does not explain the lymphadenopathy, granuloma formation, or the specific lymph node biopsy findings. B. **Induction of focal osteolysis by tumor cells**: While some malignancies can cause hypercalcemia through bone metastasis or osteolysis, this does not directly explain the lymphadenopathy or the specific lymph node biopsy findings. C. **Secretion of \u03b3-interferon by activated T-lymphocytes**: This can occur in some lymphoproliferative disorders but is not directly related to the specific histological findings or the hypercalcemia in this case. D. **Production of PTH-related peptide by malignant cells**: This is the most likely explanation. The production of PTH-related peptide (PTHrP) by malignant cells, as seen in some cases of Hodgkin lymphoma, particularly mixed cellularity subtype, can cause hypercalcemia without an increase in PTH levels. This is because PTHrP mimics the action of PTH, leading to increased calcium levels in the blood. Therefore, the most likely explanation for this patient's laboratory findings is the production of PTH-related peptide by malignant cells, which is associated with mixed cellularity Hodgkin lymphoma. Here's the output in the requested format: ```json { \"step_by_step_thinking\": \"The patient presents with systemic symptoms and lymphadenopathy, and the lymph node biopsy shows granuloma formation and large CD15-positive, CD30-positive cells with bilobed nuclei, which is consistent with mixed cellularity Hodgkin lymphoma. The hypercalcemia and low PTH levels are explained by the production of PTH-related peptide by malignant cells, a known complication of this subtype of Hodgkin lymphoma.\", \"answer_choice\": \"D\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 54.84083271026611
}